Implications of Programmed Cell Death 1 Ligand 1 Heterogeneity in the Selection of Patients With Non-Small Cell Lung Cancer to Receive Immunotherapy. (Q52883105)
Jump to navigation
Jump to search
scientific article published on 25 February 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Implications of Programmed Cell Death 1 Ligand 1 Heterogeneity in the Selection of Patients With Non-Small Cell Lung Cancer to Receive Immunotherapy. |
scientific article published on 25 February 2016 |
Statements
Implications of Programmed Cell Death 1 Ligand 1 Heterogeneity in the Selection of Patients With Non-Small Cell Lung Cancer to Receive Immunotherapy. (English)
A S Mansfield
H Dong
25 February 2016
100
3
220-222
1 reference
1 reference
1 reference
1 reference